Universal Biosensors (ASX:UBI) boosted its Q3 revenue by 50% and slashed its cash outflow, thanks to contributions from its two coagulation test strip partnerships. [ + ]

A team of researchers at The Australian National University is one step closer to better understanding how organisms function after discovering how epigenetic information is transmitted from one generation of cells to the next. [ + ]

The Australian Academy of Science has commended the government’s commitment to maintain funding for science research through the Australian Research Council (ARC) and Cooperative Research Centres (CRCs). [ + ]

Bioniche Life Sciences (ASX:BNC) has launched its first canine cancer product, Immunocidin, in the US and Canadian markets. [ + ]

Bluechiip (ASX:BCT) has partnered with Swiss laboratory systems developer Inpeco, agreeing to explore jointly developing Inpeco products with integrated Bluechiip tracking chips. [ + ]

There’s a new contender in the race to find an inexpensive alternative to platinum catalysts for use in hydrogen fuel cells - a graphene sheet covered by cobalt and cobalt-oxide nanoparticles. [ + ]

WR Grace & Co announced today that the US Patent and Trademark Office has granted three additional notices of allowance related to the company’s Reveleris flash chromatography system. [ + ]

A University of Canterbury (UC) research project, in collaboration with the University of Otago, Christchurch (formerly known as Christchurch School of Medicine), has shown some promising signs in the treatment of ovarian cancer. [ + ]

Allied Healthcare (ASX:AHZ) has reached a milestone with its CardioCel cardiovascular patch product, announcing its first surgical use outside of clinical trials. [ + ]

The state finalists of the 2012 AusBiotech/GSK Student Excellence Awards have been announced. Sixteen promising research students competed for the chance to represent their state, and the six state finalists will now compete at the AusBiotech national conference to win a $7,000 travel grant. [ + ]

Researchers from The University of Western Australia, Ondek and Sir Charles Gairdner Hospital are continuing a study into how the bacteria responsible for stomach ulcers, Helicobacter pylori, can be used as a carrier for ingestible vaccines. [ + ]

Bionomics (ASX:BNO) is presenting details of its its Alpha 7 program targeting Alzheimers and other neurodegenerative conditions at Neuroscience 2012, as it embarks on the hunt for a licensing deal. [ + ]

Specialised Therapeutics Australia (STA) has negotiated commercialisation rights for a new drug to treat cachexia-anorexia, a serious condition linked with advanced cancers. [ + ]

CSL (ASX:CSL) has announced another up to $900 million share buyback, and has affirmed its guidance for FY13. [ + ]

A new non-invasive test for colorectal cancer screening has demonstrated high sensitivity for detecting colorectal cancer; in particular, precancers that are most likely to develop into cancer. [ + ]